foxo4-dri senolytic peptide mechanism Class II senolytics inhibit survival pathways elicited by senescent Frontiers | FOXO4-DRI regulates endothelial

Frontiers FOXO4 DRI regulates endothelial cell senescence via the P53 signaling pathway Peptide Inhibitors Targeting FOXO4 p53 Interactions and Inducing Senescent Cancer Cell specific Apoptosis Journal of Medicinal Chemistry The FOXO4 peptide in a DRI conformation (D amino acids in a retro reversed sequence), henceforth named FOXO4 DRI, competes with FOXO4 for p53 binding in a dose dependent manner and doing so with higher affinity. FOXO4 DRI: Human Trial Status, Cancer Research & Senolytic Data

SKU: 4382325340 · From l2q2.es